J.P. Morgan maintains Avolta overweight with a chf55 target price, focusing on organic growth recovery and margin resilience
AI summary card
J.P. Morgan maintains Avolta overweight with a chf55 target price, focusing on organic growth recovery and margin resilience
Following the Q1 update, the report only slightly lowers 2026e ebitda by about 1%, believing the Middle East drag is easing and that improving U.S. growth and channel diversification will support H2 organic growth returning to around 5%.
- 2026e ebitda is lowered by about 1% due to a lower Q2 organic growth assumption, while 2027/28e estimates are broadly unchanged.
- Q2 organic growth is forecast at +3.5%, below Q1's +4.7%, but H2 is expected to recover to +5%.
- The Middle East drag on group organic growth was about 3 percentage points in March-April, with signs of narrowing already visible in early May.
- Management remains confident of achieving annual ebitda margin expansion of +20-40bps in 2026e within the mid-term guidance range.
- Valuation uses the average of 10x ev/ebit and 11x p/e target multiples based on 2028 forecasts, deriving a dec-27 target price of chf55.
Report interpretation
Overview
This is a J.P. Morgan company research update on Avolta. The report adjusts forecasts following Avolta's Q1 trading update: 2026e ebitda is slightly reduced by 1%, mainly reflecting a somewhat lower Q2 organic growth assumption due to the Middle East impact; 2027/28e forecasts are broadly unchanged. The analyst maintains an overweight rating and a dec-27 chf55 target price, with the core rationale being an improving Middle East drag, resilient margin growth, and global geographic and channel diversification providing a buffer during periods of macro uncertainty.
Core views
The core views include: first, the Middle East impact is improving, with some airports reopening and seasonal factors reducing the drag at the group level, and organic growth run rates in May-June likely to improve; second, although organic growth may be affected by Middle East disruption, management still expects 2026e ebitda margin to remain within the mid-term annual expansion range of +20-40bps; third, Avolta's global geographic and channel diversification is a key advantage, and accelerating U.S. organic growth in March-April helps offset weakness in emea; fourth, if 2026e organic growth stays within the +5-7% target range, it would mark a second consecutive year of resilient organic growth.
Analysis framework
The report uses earnings forecast updates, interpretation of operating segment and regional growth, assessment of management margin guidance, and a valuation framework based on target multiples. Valuation is based on 2028 forecasts, using the average of 10x ev/ebit and 11x p/e target multiples, and assumes Avolta should trade at a 30% discount to its 2014-2019 average multiples.
Methodology notes
ev/ebit and p/e multiple-based valuation
The target price is based on 2028 forecasts, using the average result of 10x ev/ebit and 11x p/e target multiples, while assuming a 30% discount to the 2014-2019 average multiples.
Post-Q1 earnings estimate revision
The analyst adjusts 2026e ebitda based on the Q1 trading update, with the main changes coming from the Q2 organic growth assumption and the impact from the Middle East region, while 2027/28e remain broadly unchanged.
Long-term growth framework for travel retail
Avolta is viewed as a beneficiary of long-term passenger growth and higher passenger spending, while improved mid-term free cash flow conversion and balance sheet deleveraging are additional investment highlights.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Avolta (AVOL.S)Core covered name, overweight rating maintained
- Strengths
- Benefits from long-term passenger traffic growth, higher passenger spending, global geographic and channel diversification, improved free cash flow conversion, rapid balance sheet deleveraging, as well as cost synergies and cross-selling opportunities following the Autogrill acquisition.
- Weaknesses
- Short-term organic growth is affected by Middle East disruption and emea weakness, with the Q2 growth assumption below Q1.
- Comparison
- The report believes Avolta should trade at a 30% discount to its 2014-2019 average valuation multiples, and derives the target price using 2028 10x ev/ebit and 11x p/e.
- Risks
- Integration synergies below expectations, loss of key contracts or prime locations, higher-than-expected capex intensity, cash conversion missing targets, slower passenger recovery, weaker consumer spending, rising concession fees, and inflation and supply chain pressure.
Key data
- RatingoverweightThe report maintains an overweight rating.
- Target Pricechf55.00The dec-27 target price is unchanged.
- Current Pricechf46.22The price date is May 22, 2026.
- 2026e ebitda Revision-1%Slightly lowered due to a somewhat lower Q2 organic growth assumption.
- Q1 Organic Growth+4.7%Used as the comparison benchmark for the Q2 forecast.
- Q2 Organic Growth Forecast+3.5%Affected by the Middle East impact, below Q1.
- H2 Organic Growth Forecast+5%The report expects H2 to recover to around 5%.
- Mid-term ebitda Margin Guidance+20-40bps/yearManagement remains confident in 2026e margin growth.
- Valuation Multiples10x ev/ebit;11x p/eApplied to 2028 forecasts and averaged.
Impact & implications
The report has a positive investment implication for Avolta: short-term Middle East disruption is slowing Q2 growth, but the drag is expected to narrow; if H2 organic growth recovers and margins expand in line with guidance, the market may refocus on its medium-term re-rating potential driven by earnings upside, improving free cash flow, deleveraging, and Autogrill integration synergies.
Risks
- Autogrill transaction cost synergies may come in below expectations, or integration costs may be higher than expected.
- Competition in travel retail is intense, and Avolta may lose key contracts or premium operating locations.
- Capital intensity or one-off cash outflows may be higher than expected, potentially causing cash conversion targets to be missed.
- Macro factors, government restrictions, airline capacity cuts, or new COVID variants may slow passenger recovery.
- A slowdown in consumer-driven demand may pressure retail spending.
- Concession fees may continue to rise, or shift back toward fixed minimum guarantee structures.
- Inflation pressures such as product costs and employee wages may squeeze retailer margins.
- Government regulation or tax changes, as well as supplier term changes or supply chain issues, may cause operational disruption.
What to watch
- Whether the Middle East drag continues to narrow in May-June, and traffic recovery after some airports reopen.
- Whether Q2 organic growth comes close to the +3.5% forecast, and whether H2 can recover to +5%.
- Whether 2026e ebitda margin achieves the mid-term guidance of +20-40bps per year.
- Whether accelerating U.S. organic growth can continue to offset emea weakness.
- Progress on cost synergies, revenue synergies, and cross-selling following Autogrill integration.
- Improvement in free cash flow conversion and the pace of balance sheet deleveraging.